The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 22, 2023
Filed:
Jul. 09, 2021
Applicant:
Astrazeneca Ab, Södertälje, SE;
Inventors:
Peter Greasley, Mölndal, SE;
Christine Ahlström, Mölndal, SE;
Stanko Skrtic, Mölndal, SE;
Robert Menzies, Mölndal, SE;
Anne-Kristina Mercier, Mölndal, SE;
Mikael Sunnåker, Mölndal, SE;
Assignee:
ASTRAZENECA AB, Södertälje, SE;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/497 (2006.01); A61P 13/12 (2006.01); A61K 31/7034 (2006.01);
U.S. Cl.
CPC ...
A61K 31/497 (2013.01); A61K 31/7034 (2013.01); A61P 13/12 (2018.01);
Abstract
The present disclosure relates to the endothelin receptor antagonist (ERA) zibotentan in combination with the sodium-dependent glucose cotransporter 2 (SGLT-2) inhibitor dapagliflozin for use in the treatment of certain endothelin related diseases.
Greasley, Peter. (2023). Combination of zibotentan and dapagliflozin for the treatment of endothelin related diseases (U.S. Patent No. 11730735). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11730735
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile